Divi's Laboratories Limited header image

Divi's Laboratories Limited

532488

Equity

ISIN INE361B01024 / Valor 3132723

Bombay Stock Exchange Ltd. (Mumbai) (2026-06-04)
INR 6,594.45+0.30%

Divi's Laboratories Limited
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Divi's Laboratories Limited is one of India's largest and most respected active pharmaceutical ingredient (API) and nutraceutical manufacturers, incorporated on October 12, 1990 and headquartered at Divi Towers, Cyber Hills, Gachibowli, Hyderabad. Founded by Dr. Murali Krishna Prasad Divi, the company manufactures APIs and intermediates for global innovator pharmaceutical companies on a custom synthesis basis, as well as generic APIs and nutraceutient ingredients. Manufacturing facilities are at Visakhapatnam (Unit I, II) and Hyderabad (Unit III). Divi's is a preferred supplier for several multi-national pharmaceutical companies and exports to 100+ countries. Revenue ₹9,712 crore FY25, net profit ₹2,194 crore. A Nifty 50 constituent. Listed on both BSE and NSE (DIVISLAB). Board meeting scheduled May 23, 2026 to approve FY26 results.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-0.35%1Y
87.6%3Y
54.8%5Y

Performance

23.4%1Y
25.2%3Y
27.0%5Y

Volatility

Market cap

18376 M

Market cap (USD)

Daily traded volume (Shares)

98,638

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Sanofi SA
Sanofi SA Sanofi SA Valor: 699381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.97%EUR 76.44
Roche Holding Ltd
Roche Holding Ltd Roche Holding Ltd Valor: 1203204
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.17%CHF 324.60
Option Care Health Inc
Option Care Health Inc Option Care Health Inc Valor: 52359365
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 20.07
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.09%CHF 83.30
Idorsia Ltd
Idorsia Ltd Idorsia Ltd Valor: 36346343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
9.77%CHF 4.45
Alkermes PLC
Alkermes PLC Alkermes PLC Valor: 13920929
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.45%USD 43.38
Medacta Group Ltd
Medacta Group Ltd Medacta Group Ltd Valor: 46852522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.47%CHF 137.80
Denali Therapeutics Inc
Denali Therapeutics Inc Denali Therapeutics Inc Valor: 39149539
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.44%USD 20.14
SHL Telemedicine Ltd
SHL Telemedicine Ltd SHL Telemedicine Ltd Valor: 1128957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 1.00
RHOEN-KLINIKUM AG
RHOEN-KLINIKUM AG RHOEN-KLINIKUM AG Valor: 341644
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.81%EUR 12.40